Multi-modal effects of 1B3, a novel synthetic miR-193a-3p mimic, support strong potential for therapeutic intervention in oncologyBryony J. Telford(Sensata Technologies (Netherlands)), Michel Janicot(Sensata Technologies (Netherlands))OncotargetMarch 2, 202110.18632/oncotarget.27894Cited by 36SaveCiteExport RISWatch citationsRelated PapersTGF-β2 silencing to target biliary-derived liver diseases|Gut|2020|43